Pre-treatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Survival in Patients with Malignant Adrenal Lesions treated with Stereotactic Body Radiotherapy (SBRT)

被引：0
|
作者：
Mills, M. [1 ]
Reddy, A. V. [2 ]
Richardson, L. [3 ]
Richardson, K. M. [3 ]
Kersh, C. R. [3 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] Johns Hopkins, Dept Radiat Oncol, Baltimore, MD USA
[3] Univ Virginia, Riverside Radiosurg Ctr, Newport News, VA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3316
引用
收藏
页码：E569 / E569
页数：1
相关论文
共 50 条
  • [31] Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer
    Gou, Miaomiao
    Qu, Tongtong
    Wang, Zhikuan
    Yan, Huan
    Si, Yanhai
    Zhang, Yong
    Dai, Guanghai
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [32] Change in the Neutrophil-to-Lymphocyte Ratio (NLR) Pre and Post Stereotactic Body Radiation Treatment (SBRT) for Stage I Non-Small Cell Lung Cancer (NSCLC): Is There a Clinical Significance?
    Chung, E.
    Biswas, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E679 - E679
  • [33] Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis
    Guo, Xin
    Jiao, Hengxing
    Zhang, Tiantian
    Zhang, Yuelin
    [J]. BRAIN SCIENCES, 2022, 12 (05)
  • [34] Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
    Capone, Mariaelena
    Giannarelli, Diana
    Mallardo, Domenico
    Madonna, Gabriele
    Festino, Lucia
    Grimaldi, Antonio Maria
    Vanella, Vito
    Simeone, Ester
    Paone, Miriam
    Palmieri, Giuseppe
    Cavalcanti, Ernesta
    Caraco, Corrado
    Ascierto, Paolo Antonio
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [35] Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
    Cho, HanByoul
    Hur, Hye Won
    Kim, Sang Wun
    Kim, Sung Hoon
    Kim, Jae Hoon
    Kim, Young Tae
    Lee, Kook
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (01) : 15 - 23
  • [36] Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
    HanByoul Cho
    Hye Won Hur
    Sang Wun Kim
    Sung Hoon Kim
    Jae Hoon Kim
    Young Tae Kim
    Kook Lee
    [J]. Cancer Immunology, Immunotherapy, 2009, 58 : 15 - 23
  • [37] Neutrophil-to-lymphocyte ratio predicts survival in patients with cancer of unknown primary
    Talasiewicz, K.
    Czachowska, A.
    Omiotek, R.
    Wojcik, A.
    Kiliszczyk, A.
    Jagielska, B.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S727 - S727
  • [38] Pre-Treatment and Post-Treatment Neutrophil-to-Lymphocyte Ratio Predict Pathological Tumor Response and Survival in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy
    Delikgoz Soykut, Ela
    Kemal, Yasemin
    Odabasi, Eylem
    Sahin, Nilgun
    Keskinkilic Yagiz, Betul
    Yazicioglu, Irem Melike
    Aytac Arslan, Suheyla
    Guney, Vildiz
    [J]. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2022, 37 (02): : 139 - 149
  • [39] Post-Stereotactic Body Radiation Therapy (SBRT) Neutrophil-to-Lymphocyte Ratio (NLR) in Patients With Borderline Resectable Pancreatic Cancer (BRPC) May Be a Prognostic Biomarker
    Pearson, A. L.
    Jin, W.
    Mellon, E. A.
    Frakes, J. M.
    Strom, T.
    Springett, G. M.
    Kim, R.
    Mahipal, A.
    Hodul, P. J.
    Pimiento, J. M.
    Shridhar, R.
    Malafa, M. P.
    Hoffe, S. E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E153 - E153
  • [40] Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
    Santoni, M.
    De Giorgi, U.
    Iacovelli, R.
    Conti, A.
    Burattini, L.
    Rossi, L.
    Burgio, S. Luca
    Berardi, R.
    Muzzonigro, G.
    Cortesi, E.
    Amadori, D.
    Cascinu, S.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 109 (07) : 1755 - 1759
12345